BTCS Inc
BTCS
Digihost Technology
DGHI
Bakkt Holdings
BKKT
Abits
ABTS
TeraWulf
WULF
US Stock MarketDetailed Quotes
KZR Kezar Life Sciences
- 6.190
- -0.150-2.37%
Close Jan 17 16:00 ET
- 6.190
- 0.0000.00%
Post 16:00 ET
45.16MMarket Cap-0.47P/E (TTM)
6.630High6.160Low110.28KVolume6.250Open6.340Pre Close690.68KTurnover2.43%Turnover RatioLossP/E (Static)7.30MShares11.35052wk High0.34P/B28.13MFloat Cap5.20252wk Low--Dividend TTM4.54MShs Float363.268Historical High--Div YieldTTM7.41%Amplitude5.200Historical Low6.263Avg Price1Lot Size
Kezar Life Sciences Key Stats
EPS
According to the latest financial report of Kezar Life Sciences, the latest earnings per share (TTM) for the company is -2.78. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Kezar Life Sciences's free cash flow? The latest report shows it as -17.51M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Kezar Life Sciences shows that the company's current ratio is 7.65, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Kezar Life Sciences, the quick ratio is 7.39, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Kezar Life Sciences? The latest ROE figure is -14.27%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Kezar Life Sciences, the total asset return on investment (ROA) is -11.81%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Kezar Life Sciences's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Kezar Life Sciences, the net profit margin is -330.04%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.